These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21677339)

  • 1. Trans-arterial (90)yttrium radioembolization for patients with unresectable tumors originating from the biliary tree.
    Wijlemans JW; Van Erpecum KJ; Lam MG; Seinstra BA; Smits ML; Zonnenberg BA; Van Den Bosch MA
    Ann Hepatol; 2011; 10(3):349-54. PubMed ID: 21677339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified response evaluation criteria in solid tumors and European Association for The Study of the Liver criteria using delayed-phase imaging at an early time point predict survival in patients with unresectable intrahepatic cholangiocarcinoma following yttrium-90 radioembolization.
    Camacho JC; Kokabi N; Xing M; Prajapati HJ; El-Rayes B; Kim HS
    J Vasc Interv Radiol; 2014 Feb; 25(2):256-65. PubMed ID: 24461131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biliary tract cancer.
    Curley SA
    Cancer Treat Res; 1997; 90():273-307. PubMed ID: 9367089
    [No Abstract]   [Full Text] [Related]  

  • 4. Intra-arterial yttrium-90 radioembolization combined with systemic chemotherapy is a promising method for downstaging unresectable huge intrahepatic cholangiocarcinoma to surgical treatment.
    Rayar M; Sulpice L; Edeline J; Garin E; Levi Sandri GB; Meunier B; Boucher E; Boudjema K
    Ann Surg Oncol; 2015 Sep; 22(9):3102-8. PubMed ID: 25623598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: a systematic review and pooled analysis.
    Al-Adra DP; Gill RS; Axford SJ; Shi X; Kneteman N; Liau SS
    Eur J Surg Oncol; 2015 Jan; 41(1):120-7. PubMed ID: 25449754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: a preliminary assessment of this novel treatment option.
    Saxena A; Bester L; Chua TC; Chu FC; Morris DL
    Ann Surg Oncol; 2010 Feb; 17(2):484-91. PubMed ID: 19876691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodal Therapy including Yttrium-90 Radioembolization as a Bridging Therapy to Liver Transplantation for a Huge and Locally Advanced Intrahepatic Cholangiocarcinoma.
    Rayar M; Levi Sandri GB; Houssel-Debry P; Camus C; Sulpice L; Boudjema K
    J Gastrointestin Liver Dis; 2016 Sep; 25(3):401-4. PubMed ID: 27689207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival.
    Hoffmann RT; Paprottka PM; Schön A; Bamberg F; Haug A; Dürr EM; Rauch B; Trumm CT; Jakobs TF; Helmberger TK; Reiser MF; Kolligs FT
    Cardiovasc Intervent Radiol; 2012 Feb; 35(1):105-16. PubMed ID: 21431970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of chemoembolization and radioembolization into multimodal treatment of cholangiocarcinoma.
    Seidensticker R; Ricke J; Seidensticker M
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):319-32. PubMed ID: 25966431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locoregional intra-arterial therapies for unresectable intrahepatic cholangiocarcinoma.
    Hong K; Geschwind JF
    Semin Oncol; 2010 Apr; 37(2):110-7. PubMed ID: 20494703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioembolization in the treatment of unresectable liver tumors: experience across a range of primary cancers.
    Coldwell D; Sangro B; Salem R; Wasan H; Kennedy A
    Am J Clin Oncol; 2012 Apr; 35(2):167-77. PubMed ID: 21127414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET response criteria for solid tumors predict survival at three months after intra-arterial resin-based 90Yttrium radioembolization therapy for unresectable intrahepatic cholangiocarcinoma.
    Camacho JC; Kokabi N; Xing M; Schuster DM; Kim HS
    Clin Nucl Med; 2014 Nov; 39(11):944-50. PubMed ID: 25140563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostics and treatment of cholangiocarcinoma].
    Mantel HT; Verdonk RC; van Dullemen HM; Gietema JA; Slooff MJ; Porte RJ
    Ned Tijdschr Geneeskd; 2008 May; 152(18):1037-41. PubMed ID: 18547024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yttrium-90 microsphere radioembolization in unresectable intrahepatic cholangiocarcinoma.
    Mosconi C; Cappelli A; Ascanio S; Pettinari I; Modestino F; Renzulli M; Galaverni MC; Cucchetti A; Gramenzi A; Pettinato C; Golfieri R
    Future Oncol; 2017 Jun; 13(15):1301-1310. PubMed ID: 28343412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma.
    Boehm LM; Jayakrishnan TT; Miura JT; Zacharias AJ; Johnston FM; Turaga KK; Gamblin TC
    J Surg Oncol; 2015 Feb; 111(2):213-20. PubMed ID: 25176325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Palliative therapy in cholangio- and gallbladder carcinoma].
    Klebl F; Endlicher E; Kullmann F
    Z Gastroenterol; 2006 Jul; 44(7):587-98. PubMed ID: 16823700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-arterial therapy for advanced intrahepatic cholangiocarcinoma: a multi-institutional analysis.
    Hyder O; Marsh JW; Salem R; Petre EN; Kalva S; Liapi E; Cosgrove D; Neal D; Kamel I; Zhu AX; Sofocleous CT; Geschwind JF; Pawlik TM
    Ann Surg Oncol; 2013 Nov; 20(12):3779-86. PubMed ID: 23846786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Y-shaped endoscopic bilateral metal stent placement for malignant hilar biliary obstruction: prospective long-term study.
    Hwang JC; Kim JH; Lim SG; Kim SS; Yoo BM; Cho SW
    Scand J Gastroenterol; 2011 Mar; 46(3):326-32. PubMed ID: 21082874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study.
    Ibrahim SM; Mulcahy MF; Lewandowski RJ; Sato KT; Ryu RK; Masterson EJ; Newman SB; Benson A; Omary RA; Salem R
    Cancer; 2008 Oct; 113(8):2119-28. PubMed ID: 18759346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cholangiocarcinoma].
    Ochoa Carrillo FJ
    Rev Gastroenterol Mex; 1997; 62(3):194-201. PubMed ID: 9480527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.